Ethos Financial Group »

Fibrobiologics shares owned by Ethos Financial Group

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by Ethos Financial Group from 13F filings

Historical chart of Ethos Financial Group investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Ethos Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Ethos Financial Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $79k 26k 3.10
2024-06-30 $127k 26k 4.99

More positions owned by Ethos Financial Group

Schwab US Broad Market ETF Etf (SCHB)
Alpha Architect 1-3 Month Box ETF Etf (BOXX)
Vaneck Morningstar Wide Moat ETF Etf (MOAT)
Schwab US Large Cap ETF Etf (SCHX)
Vanguard Total World Stock ETF Etf (VT)
Abrdn Physical Gold Shares ETF Etf (SGOL)
Schwab US Large Cap Growth ETF Etf (SCHG)
iShares TIPS Bond ETF Etf (TIP)
Schwab US Large Cap Value ETF Etf (SCHV)
Spdr S&p 500 Etf Etf (SPY)
iShares 0-5 Year TIPS Bond ETF Etf (STIP)
Apple (AAPL)
Energy Select Sector SPDR ETF Etf (XLE)
iShares Russell 1000 Growth ETF Etf (IWF)
Schwab Fundamental Inl Large Com ETF Etf (FNDF)

View all positions for Ethos Financial Group

Top funds holding Fibrobiologics

BlackRock
BlackRock
Geode Capital Management
State Street Corporation
Cascade Financial Partners
Vanguard Group
Northern Trust
Optivise Advisory Services
Requisite Capital Management
Bank of America Corporation
American Institute for Advanced Investment Management
Charles Schwab Investment Management
Advisor Group Holdings
HPM Partners
Bank of New York Mellon

View all funds holding Fibrobiologics